Terms: = Kidney tumors AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
31 results:
1. Construction of a prognostic model for autophagy in Wilm's tumor.
Shi H; Zhang M; Zhang Y
Pediatr Surg Int; 2024 May; 40(1):122. PubMed ID: 38704513
[TBL] [Abstract] [Full Text] [Related]
2. MT1X is an oncogene and indicates prognosis in ccRCC.
Ding Y; Fang J; Chen M; Xu Y; Liu N; Fang S; Xiang W; Chen R; Wu C; Yu H
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36149322
[TBL] [Abstract] [Full Text] [Related]
3. Lox as the Potential Key Gene of Clear Cell Renal Carcinoma.
Chen Y; Yan Z; Su Y; Zhao S
J Coll Physicians Surg Pak; 2022 May; 32(5):632-638. PubMed ID: 35546701
[TBL] [Abstract] [Full Text] [Related]
4. PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating cxcr4/ERK signaling pathway and accelerating glycolysis.
He Y; Wang X; Lu W; Zhang D; Huang L; Luo Y; Xiong L; Li H; Zhang P; Li Q; Liang S
Cell Death Dis; 2022 Feb; 13(2):118. PubMed ID: 35121728
[TBL] [Abstract] [Full Text] [Related]
5. Expression of the cxcr4 and CXCR7 in renal cancers; can "the orphan receptor" predict the mortality?
Floranović MP; Petrović AR; Veličković LJ
Ann Diagn Pathol; 2021 Dec; 55():151829. PubMed ID: 34563828
[TBL] [Abstract] [Full Text] [Related]
6. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma.
Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B
FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatics analysis of C3 and cxcr4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
[TBL] [Abstract] [Full Text] [Related]
8. Expression and prognostic value of CXCL12/cxcr4/CXCR7 axis in clear cell renal cell carcinoma.
Potić Floranović M; Ristić Petrović A; Veličković F; Janković Veličković L
Clin Exp Nephrol; 2021 Oct; 25(10):1057-1069. PubMed ID: 34109508
[TBL] [Abstract] [Full Text] [Related]
9.
Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
[TBL] [Abstract] [Full Text] [Related]
10. Effect of CXCL12 and Its Receptors on Unpredictable Renal Cell Carcinoma.
Floranović MP; Veličković LJ
Clin Genitourin Cancer; 2020 Aug; 18(4):e337-e342. PubMed ID: 31882334
[TBL] [Abstract] [Full Text] [Related]
11. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ
Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and prognostic significance of cxcr4 high expression in renal cell carcinoma: A meta-analysis and literature review.
Si X; Ma J; Yu F; Zhao H; Huang H; Sun YW
Int J Surg; 2019 Nov; 71():12-18. PubMed ID: 31494331
[TBL] [Abstract] [Full Text] [Related]
13. A feed-forward loop between nuclear translocation of cxcr4 and HIF-1α promotes renal cell carcinoma metastasis.
Bao Y; Wang Z; Liu B; Lu X; Xiong Y; Shi J; Li P; Chen J; Zhang Z; Chen M; Wang L; Wu Z
Oncogene; 2019 Feb; 38(6):881-895. PubMed ID: 30177838
[TBL] [Abstract] [Full Text] [Related]
14. The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and prognosis Prediction Approaches in kidney Cancer.
Liang J; Liu Z; Zou Z; Tang Y; Zhou C; Yang J; Wei X; Lu Y
Sci Rep; 2018 Apr; 8(1):6570. PubMed ID: 29700419
[TBL] [Abstract] [Full Text] [Related]
15. Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms' Tumor.
Maturu P; Jones D; Ruteshouser EC; Hu Q; Reynolds JM; Hicks J; Putluri N; Ekmekcioglu S; Grimm EA; Dong C; Overwijk WW
Neoplasia; 2017 Mar; 19(3):237-249. PubMed ID: 28254151
[TBL] [Abstract] [Full Text] [Related]
16. Versican Promotes Tumor Progression, Metastasis and Predicts Poor prognosis in Renal Carcinoma.
Mitsui Y; Shiina H; Kato T; Maekawa S; Hashimoto Y; Shiina M; Imai-Sumida M; Kulkarni P; Dasgupta P; Wong RK; Hiraki M; Arichi N; Fukuhara S; Yamamura S; Majid S; Saini S; Deng G; Dahiya R; Nakajima K; Tanaka Y
Mol Cancer Res; 2017 Jul; 15(7):884-895. PubMed ID: 28242813
[TBL] [Abstract] [Full Text] [Related]
17. NMMHC-IIA-dependent nuclear location of cxcr4 promotes migration and invasion in renal cell carcinoma.
Xu Z; Li P; Wei D; Wang Z; Bao Y; Sun J; Qu L; Wang L
Oncol Rep; 2016 Nov; 36(5):2681-2688. PubMed ID: 27634189
[TBL] [Abstract] [Full Text] [Related]
18. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Value of High cxcr4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
Du Y; Long Q; Guan B; Mu L
Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
[TBL] [Abstract] [Full Text] [Related]
20. CD117⁺ cells in the circulation are predictive of advanced prostate cancer.
Kerr BA; Miocinovic R; Smith AK; West XZ; Watts KE; Alzayed AW; Klink JC; Mir MC; Sturey T; Hansel DE; Heston WD; Stephenson AJ; Klein EA; Byzova TV
Oncotarget; 2015 Jan; 6(3):1889-97. PubMed ID: 25595903
[TBL] [Abstract] [Full Text] [Related]
[Next]
